Plant: Watson-Marlow announces details of new U.S. manufacturing facility
The new facility will be dedicated to its range of industry products, including peristaltic pumps, tubing and fluid path solutions.
Watson-Marlow announced the start of construction on a new manufacturing facility in the U.S., with first production due in late 2022.
The new facility will be dedicated to its range of industry products, including peristaltic pumps, tubing, fluid path solutions and BioPure components.
Part of Spirax-Sarco Engineering plc, a FTSE100 company, Watson-Marlow specializes in fluid management solutions for the life sciences and process industries.
Located in Devens, Massachusetts, the 150,000-square-feet facility will be close to the life sciences hub in the Cambridge/Boston area. The site will incorporate a suite of eight ISO14644-1 Class 7 cleanrooms, warehousing and offices, with space for two further cleanrooms within the initial footprint.